Introduction to Ross and Biosortia
Ross Youngs is the CEO of Biosortia, a company that focuses on the exploration of novel small molecules (SMs) from natural microbiomes.
The company recognizes the unique value of naturally occurring microbes in microbiomes as a source of biologically optimized life science starting points. With advanced technologies like machine learning and artificial intelligence, Biosortia is able to group and prioritize the activities of small molecules according to their potential.
Ross’s Background and Experience in the Life Science Industry
Ross has an impressive background in the life science industry, with a wealth of experience in environmental science and industrial engineering. He has over 75 patents globally and has been recognized for his contributions to the field with numerous awards, including the prestigious R&D 100 Award for his work on biopolymer technologies. In 2009, Biosortia received a $6 million grant from the U.S. Department of Energy’s ARPA-E program, which played a crucial role in the development of the company’s drug discovery platform.
The Beginning of Ross’s Journey in the Life Science Industry
Ross’s journey in the life science industry began in the early 1980s when he worked in the medical imaging field and video and optical disc field. He went on to start his first company, which hit the Ink 500 list of the 500 fastest growing privately held companies in the US. This recognition fueled his passion for improvement and efficiency, leading him to create new technologies for harvesting microbes from the natural world. These technologies were funded by the Department of Energy, DARPA, and the US Air Force research lab and were originally intended for biofuels. However, Ross soon realized that the technology had applications beyond biofuels, leading to the spin-off of the company to Biosortia.
The Mission and Purpose of Biosortia
The name Biosortia reflects the company’s mission of sorting and understanding the microbes found in the natural world. Ross was driven to enter this field because of the exciting opportunity to do something that had never been achieved before and the potential to have a long-term impact on the world. Biosortia has an exclusive database of natural microbiomes, which it out licenses to organizations seeking to find solutions and prioritize discovery through machine learning and artificial intelligence.
Ross’s Motivation for Starting Businesses in Different Fields
When asked about his motivation for starting businesses in different fields, Ross explains that he has always recognized the importance of making a higher contribution to humanity and solving some of the biggest problems we face. The life science industry, in particular, holds a special place in his heart because of its potential to have a long-term impact on the world, from therapeutics to agrochemical to sustainability.
The Impact of Biosortia’s Technology on the Life Science Industry
Ross’s passion and dedication to making a positive impact on the world are evident in his journey in the life science industry. His company, Biosortia, is at the forefront of technology and is poised to revolutionize the way we study and understand life sciences. The potential impact of Biosortia’s ability to harvest uncultural microbes at scale and obtain their hidden cell to cell signaling secrets is immense, with the potential to impact all of therapeutics, all of agrochemical, and even sustainability.
Conclusion: Ross’s Dedication to Making a Positive Impact on the World
In conclusion, Ross’s journey in the life science industry serves as a testament to his passion and dedication to making a positive impact on the world. Biosortia is a leading company that is making waves in the field of life sciences and has the potential to revolutionize the way we study and understand the natural world.
Discover More About Biosortia : https://biosortia.com/
Ross Youngs, CEO & Founder : https://www.linkedin.com/in/rossyoungs/
